NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

If topline were to be released around ASCO, it is possible they will follow it up, as even large pharma have on occasion, at ASCO's industry theater because they are so dang secretive, because ASCO blew confidentiality on all companies last year, and because we have Cofer. You can even restrict/define your audience at that venue. If they do that, I'd think they'd be buttressed by having prior publication on the phase III. So I won't discount the possibility of Phase III topline around ASCO solely on not submitting an abstract. If they do not submit one. JMHO.